Efficacy, Safety, and Usability of a Clinical Decision Support System for Basal-Bolus Insulin Therapy in Hospital Routine Care

被引:0
|
作者
Neubauer, Katharina M.
Mader, Julia K.
Aberer, Felix
Tuca, Alexandru
Donsa, Klaus
Augustin, Thomas
Hoell, Bernhard
Schaupp, Lukas
Beck, Peter
Plank, Johannes
Pieber, Thomas R.
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
15-OR
引用
收藏
页码:A4 / A4
页数:1
相关论文
共 50 条
  • [1] A Clinical Decision Support System for Basal-Bolus Insulin Therapy Is Moving to Hospital Routine Care: Efficacy, Safety, and Usability Confirmed
    Lichtenegger, Katharina M.
    Aberer, Felix
    Tuca, Alexandru C.
    Donsa, Klaus
    Holl, Bernhard
    Schaupp, Lukas
    Plank, Johannes
    Beck, Peter
    Fruhwald, Friedrich
    Pieber, Thomas R.
    Mader, Julia K.
    [J]. DIABETES, 2019, 68
  • [2] A clinical Decision Support System for Basal Bolus Insulin Therapy in Routine Inpatient Care: Proven Efficacy, Safety, and User Adherence
    Lichtenegger, Katharina Maria
    Aberer, Felix
    Tuca, Alexandru Christian
    Donsa, Klaus
    Hoell, Bernhard
    Schaupp, Lukas
    Beck, Peter
    Fruhwald, Friedrich
    Plank, Johannes
    Pieber, Thomas Rudolf
    Mader, Julia Katharina
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 2019, 131 : S466 - S466
  • [4] Basal-bolus Insulin Therapy through an electronic Decision Support System for stationary glycemic Control with Insulin degludec
    Hochfellner, Daniel Alexander
    Baumann, Petra Martina
    Aberer, Felix
    Simic, Amra
    Bytyqi, Lirie
    Poettler, Tina
    Holl, Bernhard
    Fahrleitner-Pammer, Astrid
    Pieber, Thomas Rudolf
    Beck, Peter
    Mader, Julia
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 2021, 133 (SUPPL 6) : 209 - 209
  • [5] Feasibility of CGM Use in Basal-Bolus Insulin Therapy with an Electronic Decision Support System in Hospitalized Patients
    Bytyqi, Kujtim
    Baumann, Petra M.
    Hochfellner, Daniel A.
    Poettler, Tina
    Simic, Amra
    Beck, Peter
    Mader, Julia K.
    [J]. DIABETES, 2022, 71
  • [6] Efficacy and Safety of Oral Semaglutide When Added to Basal, Premix, or Basal-Bolus Insulin
    Mosenzon, Ofri
    Aroda, Vanita R.
    Christiansen, Erik
    Harris, Stewart B.
    Pedersen, Karen Boje
    Tarp-Johansen, Mads Jeppe
    Zinman, Bernard
    [J]. DIABETES, 2020, 69
  • [7] Efficacy and Safety of IDegLira Versus Basal-Bolus Insulin Therapy in Patients With Type 2 Diabetes Uncontrolled on Metformin and Basal Insulin: The DUAL VII Randomized Clinical Trial
    Billings, Liana K.
    Doshi, Ankur
    Gouet, Didier
    Oviedo, Alejandra
    Rodbard, Helena W.
    Tentolouris, Nikolaos
    Gron, Randi
    Halladin, Natalie
    Jodar, Esteban
    [J]. DIABETES CARE, 2018, 41 (05) : 1009 - 1016
  • [8] Efficacy and Safety of a 24-Hour Wearable Insulin Delivery Device for Basal-Bolus Therapy in Older Adults
    Zeidan, Trisha
    Nikkel, Carla C.
    Dziengelewski, Elizabeth A.
    [J]. DIABETES, 2019, 68
  • [9] Efficacy and Safety of a Basal-Bolus Regimen of Basal Insulin Plus Insulin Glulisine in Patients With Type 2 Diabetes: A Pooled Analysis of 5 Clinical Trials
    Dailey, George
    Lin, Jay
    Wang, Edward
    [J]. DIABETES, 2012, 61 : A284 - A284
  • [10] Efficacy, usability and sequence of operations of a workflow-integrated algorithm for basal-bolus insulin therapy in hospitalized type 2 diabetes patients
    Mader, J. K.
    Neubauer, K. M.
    Schaupp, L.
    Augustin, T.
    Beck, P.
    Spat, S.
    Hoell, B.
    Treiber, G. M.
    Fruhwald, F. M.
    Pieber, T. R.
    Plank, J.
    [J]. DIABETES OBESITY & METABOLISM, 2014, 16 (02): : 137 - 146